LONDON (Reuters) - Takeda Pharmaceutical (T:4502) has made an indicative takeover proposal to British drugmaker Shire (L:SHP) worth about 46.50 pounds a share, according to two sources, one of which has direct knowledge of the matter.
Japanese firm Takeda confirmed last month that it was considering a bid for the FTSE 100 company.